PGD Intended Use Limitations Addressed In FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Mid-Atlantic Diagnostics says it will take steps to clarify the intended use of its Stripper micropipette, following a warning letter requiring the firm to submit a 510(k) for pre-implantation genetic diagnosis claims